Arena Pharmaceuticals Inc EBIT margin
Cos'è EBIT margin di Arena Pharmaceuticals Inc?
EBIT margin di Arena Pharmaceuticals Inc è -1,133,840.74%
Qual è la definizione di EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin di aziende nel Health Care settore su NASDAQ rispetto a Arena Pharmaceuticals Inc
Cosa fa Arena Pharmaceuticals Inc?
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas
Aziende con ebit margin simili a Arena Pharmaceuticals Inc
- Nimy Resources Ltd ha EBIT margin di -1,962,988.89%
- Akora Resources Ltd ha EBIT margin di -1,900,440.63%
- Deepti Alloy Steel ha EBIT margin di -1,676,280.26%
- Carpinienne de Participations ha EBIT margin di -1,474,500.00%
- Thin Film Electronics ASA ha EBIT margin di -1,362,200.00%
- Allogene Therapeutics Inc ha EBIT margin di -1,342,523.81%
- Arena Pharmaceuticals Inc ha EBIT margin di -1,133,840.74%
- Aurum Resources Ltd ha EBIT margin di -887,391.20%
- Eastern Metals ha EBIT margin di -812,601.10%
- Willow Biosciences ha EBIT margin di -803,860.14%
- Psyched Wellness ha EBIT margin di -703,101.31%
- Cannon Resources Ltd ha EBIT margin di -666,400.00%
- Tamboran Resources Ltd ha EBIT margin di -530,273.27%